1.
L MA, O J, T LL. THE INCIDENCE OF DYSLIPIDEMIA AND DIABETES MELLITUS TYPE 2 AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS USING THE FIRST LINE HIGHLY ACTIVE ANTIRETRO-VIRAL THERAPY FOR AT LEAST TWELVE MONTHS IN SOUTHERN PHILIPPINES HIV-AIDS CORE TEAM HUB. J ASEAN Fed Endocr Soc [Internet]. 2019 Jul. 17 [cited 2024 Oct. 13];34:17. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/4149